SLGN SILGAN HOLDINGS INC Insider Trading

Chief Accounting Officer Ulmer purchased 1,000 shares of SLGN at $38.11 on 2025-11-07, holding 105,321 shares post-transaction.

Ulmer Kimberly Irene, SVP & Chief Accounting Officer of Silgan Holdings Inc, purchased 1,000 shares at $38.11 on 2025-11-07, adding modestly to her existing holdings. The purchase occurred while the stock trades 33.7% below its 52-week high of $57.53 and has declined 9.5% over the past 30 days and 17.9% over the past 90 days. The company operates with a market cap of $4.0B and generated $113.3M in net income on quarterly revenue of $2.0B, though annual revenue declined 2.2% year-over-year. As Chief Accounting Officer, Ulmer's open-market acquisition represents a data point in the current price environment but the modest share count increase of 1.0% relative to her prior holdings and the absence of a broader transaction pattern requires evaluation within broader shareholder activity.

SLGN CEO Greenlee bought 7,000 shares at $38.19; stock down 32.5% from 52-week high, -9.1% in 30 days.

CEO Adam J Greenlee purchased 7,000 shares at $38.19 on 2025-10-31, increasing holdings by 2.2% to 328,164 shares total. The purchase occurs while SILGAN Holdings trades at $38.85, down 32.5% from its 52-week high of $57.53, with a -9.1% 30-day decline. Fundamentally, the company maintains a 13.78 P/E ratio with $1.5B quarterly revenue and a -2.2% annual revenue growth rate. His cross-ticker track record shows 1 prior sell at a 100.00% well-timed rate with a 90-day return of -0.5%, while his same-ticker prior sale on 2025-02-24 matched these outcomes (30d -6.8%, 90d -0.5%). The purchase follows a significant price decline but does not trigger any of the timing patterns his prior sales have demonstrated; this trade's significance lies in its scale relative to existing holdings and the current depressed price environment.

Director Allott sells 81,152 shares of SLGN for $4.5M at $55.22; holds 367,511 post-sale

Director Anthony J. Allott executed a discretionary open-market sale of 81,152 shares at $55.22 on May 16, 2025, reducing his holdings by 18.1% to 367,511 shares and generating $4,480,888.83 in proceeds. The transaction occurred near the 52-week high ($57.53), with the stock up 13.9% over the prior 30 days and up 2.6% over 90 days. Allott's prior trades at SLGN show mixed timing outcomes: his most recent SLGN sale on 2024-11-18 saw a 90-day decline of 0.4%, while two earlier 2023 sales preceded strong 90-day gains (5.4% and 9.2%), yielding a 33.3% well-timed rate at this ticker. His cross-ticker selling history shows an average 90-day return of 4.7% after his sales, reflecting a 33.33% well-timed rate—meaning his sell timing has been below average across all holdings. The company trades at a P/E of 20.80 with annual revenue declining 2.2% year-over-year against a $6.0B market cap, presenting a mature profile. This sale represents neither a liquidation nor a trivial position trim and merits routine investor attention given the substantial dollar amount and substantial percentage reduction, though the mixed prior timing record and moderate fundamentals context do not signal an urgent concern.

SLGN CEO Adam J Greenlee sold 125,000 shares for $6.8M; reduces holdings by 35.5% to 227.3K shares

Adam J Greenlee, President and CEO, executed a large discretionary sale of 125,000 shares at $54.73, reducing his holdings by 35.5% from 352.3K shares to 227.3K shares. The sale occurs near the upper end of the 52-week range ($41.32–$57.53), approximately 4.9% below the 52-week high. The company's fundamentals show mixed signals: revenue declined 6.6% year-over-year, while net income remains substantial at $100.1M on $1.7B quarterly revenue, and the stock trades at a P/E of 19.75. The CEO's substantial reduction in personal shareholding warrants investor attention given the significant stake disposition and the concurrent operating headwinds.

EVP Robert Lewis sold 20,000 SLGN shares at $53.22; post-trade holdings 152,133 shares, -11.6% from pre-transaction level

Lewis Robert B, EVP of Corp. Dev. & Admin., executed an open-market sale of 20,000 shares on 2025-02-13 at $53.22, reducing holdings from 172,133 to 152,133 shares. His cross-ticker track record shows 4 prior sells with a 50.00% well-timed rate and a 90-day average return of +1.2%, indicating his prior sales have had mixed timing outcomes. At SLGN specifically, his prior 4 trades show a 50% well-timed rate at the 90-day mark (2 of 4 sales preceded declines). The current share price of $53.68 is 6.7% below the 52-week high of $57.53, positioning this sale near a local peak relative to recent trading range. Fundamentals show annual revenue decline of -6.6% year-over-year and a P/E of 19.38, suggesting the business is experiencing headwinds that warrant monitoring of his future positioning activity.

Director Allott sold 98,394 shares of SLGN at $53.91 for $5.3M; retains 456,812 shares. Stock -6.6% YoY revenue growth, P/E 19.60.

Anthony J Allott, a director of Silgan Holdings, sold 98,394 shares at $53.91 on 2024-11-18, reducing his position by 17.7% while retaining substantial ownership of 456,812 shares post-transaction. His cross-ticker track record shows 2 prior sells with an average 90-day well-timed rate of 0.00%, meaning neither prior sale preceded a subsequent decline, and his same-ticker history at SLGN (2 prior trades in 2023) also shows zero well-timed sells at the 90-day mark. The company faces headwinds with annual revenue growth of -6.6% year-over-year, though the current P/E of 19.60 and the director's continued substantial stake suggest he retains confidence despite the liquidation. The sale itself, executed at $53.91 versus a current price of $54.29, occurred near the stock's 52-week high of $55.13 and follows a 90-day gain of 7.2%, though without scheduled-transaction disclosure flags, the timing context cannot be fully determined.